Notably, TRIM28 expression significantly impacted the prognosis of seven cancer types, including breast, lung, ovarian, brain, skin, prostate and blood cancers (Figure 5A–5L). This evidence concerns the gene TRIM28 and hematopoietic and lymphoid system neoplasm.